Smarticles Liposomal Delivery Technology

We have collected information about Smarticles Liposomal Delivery Technology for you. Follow the links to find out details on Smarticles Liposomal Delivery Technology.


Marina buys Smarticles liposomal delivery system

    https://www.in-pharmatechnologist.com/Article/2010/07/29/Marina-buys-Smarticles-liposomal-delivery-system
    Smarticles enable the delivery of active substances into a cell through either systemic or topical administration. The surface charge is fully reversible which makes the liposomes particularly suited to the delivery of encapsulated nucleic acids.

Marina Biotech Strengthens IP Estate for SMARTICLES ...

    https://drug-dev.com/marina-biotech-strengthens-ip-estate-for-smarticles-nucleic-acid-delivery-technology/
    The SMARTICLES platform allows us to pursue a number of amphoteric liposome structures with enhanced delivery properties. Our broad delivery technologies permit the development of formulations for both targeted delivery, including the use of certain peptide-based moieties, as well as delivery via multiple routes of administration, such as subcutaneous injection.

ProNAi to Couple DNAi Therapies with Marina’s Liposomal ...

    https://www.genengnews.com/topics/omics/pronai-to-couple-dnai-therapies-with-marinas-liposomal-delivery-system/
    Mar 14, 2012 · Marina Biotech’s Smarticles technology has also been licensed to Mirna Therapeutics for the delivery of miRNA mimics.

Marina Biotech Holds Option to License SMARTICLES Platform ...

    https://www.genengnews.com/topics/omics/marina-biotech-holds-option-to-license-smarticles-platform-for-gene-editing/
    SMARTICLES uses amphoteric liposomes composed of unique combinations of lipids having anionic and cationic groups that work together to enable cell uptake, provide serum stability, and provide pH-triggered endosomal escape. SMARTICLES is designed to deliver both single-stranded and double-stranded nucleic acid payload.

Marina Biotech Receives Decision to Grant Japanese Patent ...

    https://finance.yahoo.com/news/marina-biotech-receives-decision-grant-113000030.html
    Jun 05, 2014 · The claims of this National Stage Application cover delivery technology based on SMARTICLES amphoteric liposomes, which are composed of phosphatidylcholine (PC) and phosphatidylethanolamine (PE ...

Rna - Pharma

    https://www.in-pharmatechnologist.com/tag/keyword/Pharma/Rna
    Life Technologies has developed new drug delivery technology for therapeutic applications that is 100 times more potent than previous formulations. Marina buys Smarticles liposomal delivery system 29-Jul-2010 By Nick Taylor

Searching for Smarticles Liposomal Delivery Technology?

You can just click the links above. The data is collected for you.

Related Delivery Info